Abstract
The study of gene function in developmental biology has been significantly furthered by advances in antisense technology made in the early 2000s. This was achieved, in particular, by the introduction of morpholino (MO) oligonucleotides. The introduction of antisense MO oligonucleotides into cells enables researchers to readily reduce the levels of their protein of interest without investing huge financial or temporal resources, in both in vivo and in vitro model systems. Historically, the African clawed frog Xenopus has been used to study vertebrate embryological development, due to its ability to produce vast numbers of offspring that develop rapidly, in synchrony, and can be cultured in buffers with ease. The developmental progress of Xenopus embryos has been extensively characterized and this model organism is very easy to maintain. It is these attributes that enable MO-based knockdown strategies to be so effective in Xenopus. In this chapter, we will detail the methods of microinjecting MO oligonucleotides into early embryos of X. laevis and X. tropicalis. We will discuss how MOs can be used to prevent either pre-mRNA splicing or translation of the specific gene of interest resulting in abrogation of that gene’s function and advise on what control experiments should be undertaken to verify their efficacy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Movassagh, M., and Philpott, A. (2008) Cardiac differentiation in Xenopus requires the cyclin-dependent kinase inhibitor, p27Xic1, Cardiovasc Res 79, 436–447.
Nagao, K., Taniyama, Y., Kietzmann, T., Doi, T., Komuro, I., and Morishita, R. (2008) HIF-1alpha signaling upstream of NKX2.5 is required for cardiac development in Xenopus, J Biol Chem 283, 11841–11849.
Kumano, G., Ezal, C., and Smith, W. C. (2006) ADMP2 is essential for primitive blood and heart development in Xenopus, Dev Biol 299, 411–423.
Inui, M., Fukui, A., Ito, Y., and Asashima, M. (2006) Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis, Dev Biol 298, 188–200.
Zhang, C., Basta, T., and Klymkowsky, M. W. (2005) SOX7 and SOX18 are essential for cardiogenesis in Xenopus, Dev Dyn 234, 878–891.
Garriock, R. J., D’Agostino, S. L., Pilcher, K. C., and Krieg, P. A. (2005) Wnt11-R, a protein closely related to mammalian Wnt11, is required for heart morphogenesis in Xenopus, Dev Biol 279, 179–192.
Small, E. M., Warkman, A. S., Wang, D. Z., Sutherland, L. B., Olson, E. N., and Krieg, P. A. (2005) Myocardin is sufficient and necessary for cardiac gene expression in Xenopus, Development 132, 987–997.
Hilton, E. N., Manson, F. D., Urquhart, J. E., Johnston, J. J., Slavotinek, A. M., Hedera, P., Stattin, E. L., Nordgren, A., Biesecker, L. G., and Black, G. C. (2007) Left-sided embryonic expression of the BCL-6 corepressor, BCOR, is required for vertebrate laterality determination, Hum Mol Genet 16, 1773–1782.
Bartlett, H. L., and Weeks, D. L. (2008) Lessons from the lily pad: Using Xenopus to understand heart disease, Drug Discov Today Dis Models 5, 141–146.
Draper, B. W., Morcos, P. A., and Kimmel, C. B. (2001) Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown, Genesis 30, 154–156.
Heasman, J., Kofron, M., and Wylie, C. (2000) Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach, Dev Biol 222, 124–134.
Nutt, S. L., Bronchain, O. J., Hartley, K. O., and Amaya, E. (2001) Comparison of morpholino based translational inhibition during the development of Xenopus laevis and Xenopus tropicalis, Genesis 30, 110–113.
Moulton, J. D. (2007) Using morpholinos to control gene expression, Curr Protoc Nucleic Acid Chem Chapter 4, Unit 4 30.
Summerton, J. E. (2007) Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity, Curr Top Med Chem 7, 651–660.
Bill, B. R., Petzold, A. M., Clark, K. J., Schimmenti, L. A., and Ekker, S. C. (2009) A primer for morpholino use in zebrafish, Zebrafish 6, 69–77.
Eisen, J. S., and Smith, J. C. (2008) Controlling morpholino experiments: don’t stop making antisense, Development 135, 1735–1743.
Morcos, P. A. (2007) Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos, Biochem Biophys Res Commun 358, 521–527.
Dagle, J. M., and Weeks, D. L. (2001) Oligonucleotide-based strategies to reduce gene expression, Differentiation 69, 75-82.
Knudsen, H., and Nielsen, P. E. (1996) Antisense properties of duplex- and triplex-forming PNAs, Nucleic Acids Res 24, 494–500.
Ubbels, G. A., Hara, K., Koster, C. H., and Kirschner, M. W. (1983) Evidence for a functional role of the cytoskeleton in determination of the dorsoventral axis in Xenopus laevis eggs, J Embryol Exp Morphol 77, 15–37.
Summerton, J. E. (2005) Endo-Porter: a novel reagent for safe, effective delivery of substances into cells, Ann N Y Acad Sci 1058, 62–75.
Falk, J., Drinjakovic, J., Leung, K. M., Dwivedy, A., Regan, A. G., Piper, M., and Holt, C. E. (2007) Electroporation of cDNA/Morpholinos to targeted areas of embryonic CNS in Xenopus, BMC Dev Biol 7, 107.
Christine, K. S., and Conlon, F. L. (2008) Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline, Dev Cell 14, 616–623.
Brown, D. D., Martz, S. N., Binder, O., Goetz, S. C., Price, B. M., Smith, J. C., and Conlon, F. L. (2005) Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis, Development 132, 553–563.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tandon, P., Showell, C., Christine, K., Conlon, F.L. (2012). Morpholino Injection in Xenopus . In: Peng, X., Antonyak, M. (eds) Cardiovascular Development. Methods in Molecular Biology, vol 843. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-523-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-61779-523-7_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-522-0
Online ISBN: 978-1-61779-523-7
eBook Packages: Springer Protocols